This article is part of the supplement: Gout and Hyperuricemia
Epidemiology, risk factors, and lifestyle modifications for gout
-
* Corresponding author: Kenneth G Saag ksaag@uab.edu
Arthritis Research & Therapy 2006, 8(Suppl 1):S2 doi:10.1186/ar1907
Accesses
- Last 30 days: 352 accesses
- Last year: 3505 accesses
- All time: 27530 accesses
Cited by
BioMed Central: 3 citations
|
Research article
The prevalence of rheumatic diseases in central Greece: a population survey Ioannis Anagnostopoulos, Elias Zinzaras, Ioannis Alexiou, Aphrodite A Papathanasiou, Evangelos Davas, Athanasios Koutroumpas, Georgia Barouta, Lazaros I Sakkas BMC Musculoskeletal Disorders 2010, 11:98 (26 May 2010) |
|
Review
Gout. Novel therapies for treatment of gout and hyperuricemia Robert Terkeltaub Arthritis Research & Therapy 2009, 11:236 (23 July 2009) This article is part of a collection on Gout |
|
Research article
A pilot study of IL-1 inhibition by anakinra in acute gout Alexander So, Thibaut De Smedt, Sylvie Revaz, Jürg Tschopp Arthritis Research & Therapy 2007, 9:R28 (12 March 2007) In a pilot study on 10 patients with gouty arthritis, IL-1 blockade with anakinra gave rapid relief of inflammatory symptoms where standard treatments had failed or were not tolerated.
|